Theodore Brasky M PhD

Theodore Brasky M PhD
Res Asst ProfessorCollege of Medicinebrasky.1@osu.edu
Suite 525 Gateway Building C 1590 N High Street Columbus Ohio 43201
Phone:614-293-3772Fax:
  • Cancer Control

Research Description

My overarching interest is to develop a further understanding of the association of inflammation and cancer; specifically through the study of substances and genes hypothesized to affect inflammation. I have been involved in the study of non-steroidal anti-inflammatory drugs and the risk of several cancers including breast, prostate, lung, uterus, and hematologic malignancies. In addition, I have an expanding interest in the study of diet and dietary supplements, components of which may affect inflammatory processes, and their association with cancer risk and survival.

Current Publications

  • Brasky TM, Liu J, White E, Peters U, Lane DS, Manson JE, Vitolins MZ, Allison MA, Tang JY, Potter JD, Walter RB, Baik CS, Wactawski-Wende JNon-steroidal anti-inflammatory drugs and cancer risk in women: Results from the Women's Health Initiative.Int J Cancer 135 1869-83 10/15/2014
  • Llanos AA, Brasky TM, Mathew J, Makambi KH, Marian C, Dumitrescu RG, Freudenheim JL, Shields PGGenetic variation in adipokine genes and associations with adiponectin and leptin concentrations in plasma and breast tissue.Cancer Epidemiol Biomarkers Prev 23 1559-68 8/1/2014
  • Brasky TM, Thompson IM, King IB, Kristal ARResponse.J Natl Cancer Inst 106 dju021 4/1/2014
  • Brasky TM, Neuhouser ML, Cohn DE, White EAssociations of long-chain ω-3 fatty acids and fish intake with endometrial cancer risk in the VITamins And Lifestyle cohort.Am J Clin Nutr 99 599-608 3/1/2014
  • Brasky TM, Li Y, Jaworowicz DJ Jr, Potischman N, Ambrosone CB, Hutson AD, Nie J, Shields PG, Trevisan M, Rudra CB, Edge SB, Freudenheim JLPregnancy-related characteristics and breast cancer risk.Cancer Causes Control 24 1675-85 9/1/2013
  • Brasky TM, Darke AK, Song X, Tangen CM, Goodman PJ, Thompson IM, Meyskens FL Jr, Goodman GE, Minasian LM, Parnes HL, Klein EA, Kristal ARPlasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.J Natl Cancer Inst 105 1132-41 8/7/2013
  • Walter RB, Brasky TM, Buckley SA, Potter JD, White EHeight as an explanatory factor for sex differences in human cancer.J Natl Cancer Inst 105 860-8 6/19/2013
  • Llanos AA, Brasky TM, Dumitrescu RG, Marian C, Makambi KH, Kallakury BV, Spear SL, Perry DJ, Convit RJ, Platek ME, Adams-Campbell LL, Freudenheim JL, Shields PGPlasma IGF-1 and IGFBP-3 may be imprecise surrogates for breast concentrations: an analysis of healthy women.Breast Cancer Res Treat 138 571-9 4/1/2013
  • He K, Han X, Li J, Brasky TM, Xun P, Stevens J, White E, Gammon MDAntioxidant intake and pancreatic cancer risk: the Vitamins and Lifestyle (VITAL) Study.Cancer 119 1314-20 4/1/2013
  • He K, Xun P, Brasky TM, Gammon MD, Stevens J, White ETypes of fish consumed and fish preparation methods in relation to pancreatic cancer incidence: the VITAL Cohort Study.Am J Epidemiol 177 152-60 1/15/2013
  • Brasky TM, Moysich KB, Cohn DE, White ENon-steroidal anti-inflammatory drugs and endometrial cancer risk in the VITamins And Lifestyle (VITAL) cohort.Gynecol Oncol 128 113-9 1/1/2013
  • Brasky TM, Crowe FL, Kristal ARn-3 Fatty acids and prostate cancer risk.Br J Nutr 108 1721 11/14/2012
  • Brasky TM, Baik CS, Slatore CG, Alvarado M, White EPrediagnostic nonsteroidal anti-inflammatory drug use and lung cancer survival in the VITAL study.J Thorac Oncol 7 1503-12 10/1/2012

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu